About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Illinois | 25,050 Studies Near You

Clinical TrialsIllinois

Clinical Trials in Illinois

Discover 25,050 clinical trials near Illinois. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 101-120 of 25,050 trials

Active not recruitingA Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple MyelomaThe purpose of this study is to evaluate the overall minimal residual disease (MRD) negative rate of participants who receive JNJ-68284528.NCT04133636·San Diego, California and 46 others

Find Trials by Condition in Illinois

Breast Cancerin Illinois Lung Cancerin Illinois Prostate Cancerin Illinois Colorectal Cancerin Illinois Melanomain Illinois Leukemiain Illinois Lymphomain Illinois Pancreatic Cancerin Illinois Ovarian Cancerin Illinois Brain Cancerin Illinois Diabetes

Data from ClinicalTrials.govTerms

Active not recruitingA Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia AreataThe purpose of this study is to learn about the safety and effects of the study medicine (called ritlecitinib) for the possible treatment of severe alopecia areata.NCT07029711·Irvine, California and 83 others

CompletedOnce-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in NarcolepsyThe purpose of this study is to determine whether once-nightly FT218 is safe and effective for the treatment of excessive daytime sleepiness and cataplexy in subjects with…NCT02720744·Anniston, Alabama and 56 others

CompletedA 6-month Clinical Study to Evaluate the Effect of a Digital Disease Management Tool in Patients With T2DMType 2 diabetes mellitus is a complex, chronic disease that requires a comprehensive treatment plan aimed at meeting multitude therapeutic targets associated with micro- and…NCT03090464·Birmingham, Alabama and 45 others

CompletedCombination Margetuximab, Retifanlimab, Tebotelimab, and Chemotherapy Phase 2/3 Trial in HER2+ Gastric/GEJ CancerThis is a Phase 2/3, randomized, open-label study for the treatment of patients with HER2-positive Gastric cancer (GC) or Gastroesophageal Junction (GEJ) cancer conducted in two…NCT04082364·Scottsdale, Arizona and 72 others

CompletedTucatinib, Palbociclib and Letrozole in Metastatic Hormone Receptor Positive and HER2-positive Breast CancerThis is a multicenter run-in phase Ib / roll-over phase II study of triple targeted drug combination (HER2-targeted small molecule inhibitor tucatinib, CDK4/6 inhibitor…NCT03054363·Tucson, Arizona and 5 others

CompletedStudy of Oral Fampridine-SR in Multiple SclerosisTo assess the safety and efficacy of 10 milligram (mg) twice a day (b.i.d.) Fampridine-SR in patients diagnosed with multiple sclerosis (MS), in a double-blind…NCT00127530·Birmingham, Alabama and 33 others

CompletedStudy to Evaluate the Efficacy and Safety of MEDI9929 (AMG 157) in Adult Subjects With Inadequately Controlled, Severe AsthmaThe primary objective of the study is to evaluate the effect of 3 dose levels of MEDI9929 (AMG 157) on asthma exacerbations in adult subjects with inadequately controlled, severe…NCT02054130·Los Angeles, California and 106 others

CompletedEffect of SNF472 on Progression of Cardiovascular Calcification in End-Stage-Renal-Disease (ESRD) Patients on Hemodialysis (HD)The primary objective is to assess the effect of 2 dose levels of SNF472 (300 mg and 600 mg) compared to placebo on the progression of coronary artery calcium volume score over a…NCT02966028·Bakersfield, California and 74 others

Unknown5-day Defibrotide Treatment for Hepatic SOS/VODSinusoidal Obstruction Syndrome (SOS), also referred to as hepatic veno-occlusive disease (VOD), is rare but serious complication of allogeneic stem cell transplantation…NCT04313036·Maywood, Illinois

RecruitingProspective Evaluation of Complex Adult Spinal Deformity (CAD) Treated With Minimally Invasive SurgeryEvaluate surgical treatment outcomes and identify best practice guidelines for complex adult spinal deformity (ASD) patients treated with minimally invasive approach, including…NCT04885244·Phoenix, Arizona and 11 others

CompletedStudy of Regorafenib After Sorafenib in Patients With Hepatocellular CarcinomaThe objective of this study was to evaluate efficacy and safety of regorafenib in patients with advanced liver cancer who had progressed after sorafenib treatment.NCT01774344·Los Angeles, California and 146 others

RecruitingNBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With SchizophreniaThe primary objective for this study is to evaluate the efficacy of NBI-1117568 compared with placebo on improving behavioral and psychological symptoms of schizophrenia in adults.NCT06963034·Bryant, Arkansas and 20 others

TerminatedThe Hunger Elimination or Reduction Objective (HERO ) Open -Label Extension (OLE) TrialThe goal of this clinical trial is to learn if ARD-101 works to treat hyperphagia-related behavior in patients with Prader-Willi syndrome (PWS) when used in a long term setting.NCT07197034·Birmingham, Alabama and 29 others

TerminatedBucillamine in Treatment of Patients With COVID-19This is a Phase 3, multi-center, randomized, double blind, placebo controlled, clinical study of bucillamine (2 dosage levels) in patients with mild-moderate COVID-19.NCT04504734·Cullman, Alabama and 46 others

CompletedA Physical Activity Program to Disrupt Sedentary Time in Older LatinosTo test the feasibility of an intervention designed to replace sedentary time with physical activity in older Latinos, delivered in their homes to improve cognitive function and…NCT04507464·Chicago, Illinois

CompletedGemcitabine in Treating Patients With Recurrent or Persistent Endometrial CancerThis phase II trial is studying the side effects of gemcitabine and to see how well it works in treating patients with recurrent or persistent endometrial cancer.NCT00820898·Hartford, Connecticut and 19 others

RecruitingAccelerometer Measured Early Recovery After Prolapse SurgeryThe AccelERate study will evaluate the physical recovery of patients who have undergone Pelvic Organ Prolapse (POP) surgery.NCT07218016·San Diego, California and 6 others

CompletedStudy of AC-201 in Patients With Type 2 Diabetes MellitusThis is a 24-week randomized placebo-controlled study to investigate the effect of an oral IL-1beta inhibitor AC-201 in patients with type 2 diabetes mellitus already treated on…NCT01276106·Chino, California and 20 others

CompletedA Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease PsychosisThe purpose of this study is to evaluate the safety and efficacy of 40 mg pimavanserin compared to placebo in patients with Parkinson's disease psychosis (PDP).NCT01174004·Gilbert, Arizona and 62 others

PreviousPage 6 of 1253Next

in Illinois

Heart Diseasein Illinois